$维升药业-B(02_老虎社区_美港股上老虎

周大少
2025-10-22

$维升药业-B(02561)$ 合作伙伴Ascendis的隆培生长激素获FDA成人适应症批准，那韦培肽在美获优先审评，侧面印证了TransCon技术平台的全球竞争力，也让我们更看好维升管线的全球潜力

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":491914686165528,"tweetId":"491914686165528","gmtCreate":1761116956436,"gmtModify":1761116958375,"author":{"id":4214400421682690,"idStr":"4214400421682690","authorId":4214400421682690,"authorIdStr":"4214400421682690","name":"周大少","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02561\">$维升药业-B(02561)$ </a> 合作伙伴Ascendis的隆培生长激素获FDA成人适应症批准，那韦培肽在美获优先审评，侧面印证了TransCon技术平台的全球竞争力，也让我们更看好维升管线的全球潜力</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02561\">$维升药业-B(02561)$ </a> 合作伙伴Ascendis的隆培生长激素获FDA成人适应症批准，那韦培肽在美获优先审评，侧面印证了TransCon技术平台的全球竞争力，也让我们更看好维升管线的全球潜力</p></body></html>","text":"$维升药业-B(02561)$ 合作伙伴Ascendis的隆培生长激素获FDA成人适应症批准，那韦培肽在美获优先审评，侧面印证了TransCon技术平台的全球竞争力，也让我们更看好维升管线的全球潜力","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/491914686165528","repostId":0,"isVote":1,"tweetType":1,"viewCount":917,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02561"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":163,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}